Sign in
4

Changes in Ownership

CLOVER HEALTH INVESTMENTS, CORP. /DE Filed Acc 0001971702-26-000017

CEO, Counterpart Health sold 300,000 shares at $4.72 ($1,416,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wai Conrad CEO, Counterpart Health 2026-09-15 Sale 10b5-1 −300,000 $4.72 $1,416,000 1,170,056 I: show line 1 in the form
Open-market sales · 300,000 sh · avg $4.72 · $1,416,000
Loading xslF345X06/wk-form4_1789590444.xml…